Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice.
about
Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies.Relationship of blood pressure to retinal vessel diameter in type 1 diabetes mellitusDeletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet.Atherosclerosis in chronic kidney disease: the role of macrophagesLong-term clinical experience with zofenopril.MRI biomarkers for evaluation of treatment efficacy in preclinical diabetic retinopathy.Zofenopril plus hydrochlorothiazide combination in the treatment of hypertension: an update.Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases.Cardiovascular changes in spontaneously hypertensive rats are improved by chronic treatment with zofenopril.Zofenopril attenuates injury induced by ischemia-reperfusion on rat ovary.Effects of the concomitant administration of xanthine oxidase inhibitors with zofenopril or other ACE-inhibitors in post-myocardial infarction patients: a meta-analysis of individual data of four randomized, double-blind, prospective studies.
P2860
Q33607150-387CD96E-6227-4E79-BB71-69329A1E5C2CQ34156613-BE0B2DEE-F2C3-423A-9DEE-9E43D2453036Q34763602-A216DA79-130D-45D0-AE2F-1E9C581A6AE2Q37811885-4B673457-68A8-4087-AE2E-BA9C0C4BE4B3Q38048833-9109F900-1E52-4B80-8333-CC18094E9C44Q38115815-814B38FB-8D1E-4464-A954-7D0E5B586F50Q38237435-0BA86A6A-788F-4F19-8357-C09B68629C78Q38299279-FCEB7477-1D55-4DC5-B0BC-B0CF93C8D9FEQ42935846-C8733109-F6EA-4643-98CA-0FC980FB1D64Q51066660-83941114-1B88-4E45-8E10-7ADAF09CF5A8Q55491756-66A6866A-3902-40F4-BC38-C01C5BDE3B8E
P2860
Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Chronic treatment with sulfhyd ...... polipoprotein E knockout mice.
@en
Chronic treatment with sulfhyd ...... polipoprotein E knockout mice.
@nl
type
label
Chronic treatment with sulfhyd ...... polipoprotein E knockout mice.
@en
Chronic treatment with sulfhyd ...... polipoprotein E knockout mice.
@nl
prefLabel
Chronic treatment with sulfhyd ...... polipoprotein E knockout mice.
@en
Chronic treatment with sulfhyd ...... polipoprotein E knockout mice.
@nl
P2093
P50
P1476
Chronic treatment with sulfhyd ...... apolipoprotein E knockout mice
@en
P2093
P304
107-15; discusssion 115-6
P356
10.1016/S0167-5273(01)00542-3
P407
P50
P577
2001-12-01T00:00:00Z